3RD-GENERATION CEPHALOSPORINS

Authors
Citation
Nc. Klein et Ba. Cunha, 3RD-GENERATION CEPHALOSPORINS, The Medical clinics of North America, 79(4), 1995, pp. 705-719
Citations number
41
Categorie Soggetti
Medicine, General & Internal
ISSN journal
00257125
Volume
79
Issue
4
Year of publication
1995
Pages
705 - 719
Database
ISI
SICI code
0025-7125(1995)79:4<705:3C>2.0.ZU;2-Q
Abstract
Third-generation cephalosporins have broad-spectrum microbiologic acti vity, a low incidence of adverse effects, and proven clinical efficacy for a wide variety of infections. No single cephalosporin is useful f or all clinical situations because cephalosporins differ in their gram -positive, gram-negative, and anaerobic spectrum, serum half-life, pen etration of cerebrospinal fluid, and beta-lactamase resistance. Cefota xime and ceftizoxime have the best gram-positive activity of the third -generation agents whereas ceftazidime, with its long half-life, can b e dosed once daily and is useful for outpatient antibiotic therapy.